How SGLT2 Inhibitors and GLP-1 Agonists are Transforming CKD Care
Dr. Katherine Tuttle, a leading nephrologist and researcher, discusses how groundbreaking therapies are reshaping the future of kidney care, offering hope for patients living with chronic kidney disease and redefining the role of nephrologists in value-based care.
▶︎
How SGLT2 Inhibitors Protect The Kidney
▶︎
A Patient’s Perspective on Kidney Care
▶︎
Chronic Kidney Disease and GLP-1 RAs
▶︎
Psychiatrist Shares His Experience With GLP1 Weight Loss Drugs
▶︎
What are SGLT2 inhibitors and how do they affect kidney disease?
▶︎
SGLT2 inhibitors mechanism of action in CKD, Diabetes and Heart failure - EXPLAINED
▶︎
Can Xenotransplantation Solve the Kidney Transplant Shortage?
▶︎
GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show
▶︎
Fatty Liver Expert: The Toxic Ingredient Silently Filling Your Liver With Fat - Dr David Unwin
▶︎
WHAT DEMENTIA LOOKS LIKE BEFORE MEMORY LOSS STARTS — Know This to Protect Yourself!
▶︎
Summary of the NICE CKD guideline
▶︎
How do GLP-1 Agonists Work? (EASY Pharmacology)
▶︎
Europe Has Become a War Project — Can It Be Stopped? | Yanis Varoufakis & Jeffrey Sachs
▶︎
The New IgA Nephropathy Treatments That Actually Slow Kidney Damage
▶︎
Accessible Podcast S5E10 - Medicaid & Disability Services in Missouri with Sheila Wunning
▶︎
Exploring CMS’s Kidney Care Choices Model
▶︎
Every Employee Has to Matter with Louis Fordham
▶︎
Normal Cholesterol But Still Getting Heart Disease? Here's Why | Dr. Mark Hyman
▶︎
The EXACT Moment I Stopped Fearing Dementia
▶︎